Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Duchenne UK
We fund more research than anyone else
    • Search for clinical trials
    • Donate
    • Twitter
    Menu
    • About Duchenne
      • What is Duchenne
      • Diagnosing Duchenne
      • Stages Of Duchenne
      • Current Treatments
      • Supporting Therapies
      • Treatments In The Pipeline
      • Understanding Clinical Trials
      • Clinical Trial Finder
    • Patient and Parent Support
      • What to do in an emergency
      • Coronavirus Resources
      • Our message for you
      • Caring for your child
      • Resources for parents
      • Free Information Days
      • Medical Care Guidelines
      • Decipha - education support
      • Patient and Parent Stories
      • Caring during the coronavirus pandemic
    • What We Do
      • Our Mission
      • Our Impact
      • Funding Research & Trials
      • Accelerating Drug Timeline
      • Community Engagement
      • DMD Care UK
      • DMD Hub
      • Project HERCULES
      • About Us
        • Meet The Team
        • President & Patrons
        • Scientific Advisory Board
        • Patient Advisory Board
        • Donor Advisory Board
        • Trustees
        • Joining Jack
        • Alex's Wish
        • Duchenne Now
      • Watch Our Film
      • Subscribe to our PODCAST
    • Support Us
      • Duchenne Dash
      • Donate a Day
      • How You Can Help
      • Why Support Us?
      • Family and Friends Funds
      • Duchenne Direct
      • Fundraising Events
      • World's Strongest Boys
      • Corporate Support
    • News
    • Admin
      • Log in
    • Basket: (0 items)

    Our Mission To End Duchenne

    Duchenne Muscular Dystrophy (DMD) is a devastating muscle-wasting disease. It is the most common and severe form of Muscular Dystrophy. Diagnosed in childhood, it mainly affects boys. There is currently no cure. Started by families affected by the disease, Duchenne UK has one clear aim – to end Duchenne.

    We’re doing this by funding research that’s focused on getting treatments to those affected now – as well as pushing for an effective treatment in the future.

    We connect leading researchers with industry, the NHS and patients to challenge every stage of drug development, from research to clinical trials to drug approval. We connect families with each other to create a network of mutual support and to pool our resources, knowledge and experience. We connect brilliant people and generous philanthropists to grow our impact and help them be part of something incredible – the end of Duchenne.

    Together we’ve created new infrastructure to deliver clinical trials through the DMD Hub, and we fund doctors, nurses, physiotherapists and trial coordinators needed to run trials. We’ve uncovered treatments and enabled them to be delivered to patients. We’ve successfully campaigned to enable quicker access to new treatments. And through Project HERCULES, we have established an innovative way to connect leading DMD drug developers to collaborate to speed up access to treatments.

    Our heart and soul, and our reason for carrying on, are our boys and men, and rare girls, living with DMD.

    This collaborative approach means that we are able to focus on ending Duchenne as quickly and effectively as possible.

    And it means you can be part of it too.

    Together, we will end Duchenne.


    We have achieved some incredible results, with the help of donors, partner charities and researchers, for details please read:  Our Impact.


    We have an innovative approach to funding. Not only do we fund basic research, but we fund clinical trials. We fund the doctors and nurses in the UK to deliver those trials: and we look at where ever possible, we can accelerate research and work with industry and regulators to get drugs approved.

    To achieve our mission, we adopt an integrated approach that has 3 main areas of activity/focus.

    1) Funding Research and Trials:

    Our approach is sharply focused on advancing research – and getting treatments into the clinic and to patients as quickly as possible. We actively seek out projects and possible therapies that could benefit this generation of patients. We invest globally in both basic science and translational research.

    Read more here about the research projects and clinical trials that we fund. 

    2) Accelerating Drug Development:

    Funding the research is the first crucial step. But funding research on its own it isn’t enough. So we proactively invest in every stage of the drug development timeline to improve and accelerate the process.

    Read more here about how we accelerate drug development through our own initiatives and by working both globally and in the UK with industry, governments and health providers. 

    3) Community Engagement & Support:

    Patients with DMD are at the heart of everything we do. Duchenne UK was set up by parents to fight every day to speed up treatments for all those living with DMD. Our drive and ambition comes from our deep understanding of the pain and the challenges that families face. 

    Read here about how we engage with the Duchenne community and collaborate with other charities to improve the life of those living with Duchenne.

    Duchenne UK is a member of the AMRC.

    READ OUR IMPACT REPORT 2020

    Published: 1st December, 2020

    Updated: 23rd December, 2020

    Author: Nick Crossley

    Related topics:
    • What We Do
    Share this page
    • Email
    • Facebook
    • Twitter
    DMD Hub

    DMD Hub

    Expanding Clinical trial capacity Read more

    Published: 1st March, 2015

    Updated: 26th June, 2019

    Author: Nick Crossley

    Related topics:
    • Accelerating Drug Development
    Attend our FREE Information Days

    Attend our FREE Information Days

    Please join us at our free Patient Information Day Read more

    Published: 27th July, 2017

    Updated: 13th October, 2020

    Author: Nick Crossley

    Comments: 1

    Related topics:
    • Community Engagement and Support
    Impact Report 2020

    Impact Report 2020

    Despite the challenges of 2020, Duchenne UK has achieved much and we hope you find the impact report that we are releasing today, uplifting. Thank you for your support and we wish you a safe and bright 2021. Read more

    Published: 23rd December, 2020

    Updated: 27th January, 2021

    Author: Nick Crossley

    Related topics:
    • News

    Latest tweet

    Sign up for our newsletter

    Please enter your first name
    Please enter your last name
    Please enter your email address Please enter a valid email address (e.g. [email protected])

    • Twitter
    • Facebook
    • Instagram
    • LinkedIn
    • Youtube

    Contact UsPrivacy Policy

    Registered Charity No. 1147094. © 2020 Duchenne UK. All rights reserved.
    A non profit company limited by guarantee. Registered in England No. 8030768

    Our mailing address is: Duchenne UK, Unit G20, Shepherd’s Building, Charecroft Way, Hammersmith, W14 0EE


    We will always store your personal details securely. We’ll use them to provide the service that you have requested, and communicate with you in the way(s) that you have agreed to. Your data may also be used for analysis purposes, to help us provide the best service possible. For full details see our Privacy Policy or contact us on [email protected]